-
programs sponsored by the National Institutes of Health and the pharmaceutical industry. Reporting to and under the direct supervision of the Research Manager, the incumbent will perform entry-level duties
-
Institutes of Health (NIH)-sponsored T32 training grant, state of the art shared equipment, research services programs and a seminar series. Full salary range: $45,936 - $54,037.44 (expected salary range
-
Institutes of Health. Preferred: Knowledge of Kuali Financial System Minimum of one year of UC experience managing multi-million-dollar research awards. Ability to work independently and proactively advise
-
an National Institutes of Health (NIH)-sponsored T32 training grant, state of the art shared equipment, research services programs and a seminar series. Job duties include, but are not limited to: Animal care
-
: UCI Campus- Irvine Percent of Time: 100% Work Schedule: 8-5, M-F Employee Class: Career Position Summary: Ranked among the top neurology departments in the country by the National Institutes of Health
-
. institutions receiving National Institutes of Health grants for vision research. Our goal is to spark innovation and continue to revolutionize patient care. Involves collaborative care with the cornea service in
-
. institutions receiving National Institutes of Health grants for vision research. Our goal is to spark innovation and continue to revolutionize patient care Involves recommending, developing, implementing
-
coordinate projects related to improving care for older adults with serious illness. The most substantial of these is a National Institutes of Health (NIH)-funded project aimed at improving hospice care for
-
echelons of U.S. institutions receiving National Institutes of Health grants for vision research. Our goal is to spark innovation and continue to revolutionize patient care. Involves recommending, developing
-
institutions in the nation. For the 16th year in a row, UCSF garnered the top spot among public institutions in funding from the National Institutes of Health (NIH) in 2022. The Department’s clinical enterprise